AzTrials
AzTrials

Multiple SclerosisGroupCoreSITNCT02522962

Innovative Physiotherapy and Coordination of Care for People With MS: a RCT and a Qualitative Study

A study testing GroupCoreSIT in people with Multiple Sclerosis, run by Nordlandssykehuset HF at 1 site in Norway.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This project comprises a two-arm randomized controlled trial (RCT) complemented by qualitative research on innovative group-based intervention for people with Multiple Sclerosis (MS) performed in the primary health care and organized in collaboration with the services provided by a hospital's outpatient clinic. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Multiple Sclerosis
What is being tested?
GroupCoreSIT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteNorway
Study dates
Sep 2015to Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of MS (McDonald's criteria)
  • EDSS 1-6.5 (minimal symptoms - able to walk 20 minimum meter with two crutches)
  • Minimum 14 days post exacerbation
  • Age >18 years
  • Capable to provide signed written informed consent

Who cannot join

  • Pregnancy at enrolment
  • Acute orthopedic conditions affecting balance and walking

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Physiotherapy department, Nordlandssykehuset HF

    Bodø

Other trials in Norway

About this study

Official title: Innovative Physiotherapy and Coordination of Care for People With Multiple Sclerosis: a Randomised Controlled Trial and a Qualitative Study

This project comprises a two-arm randomized controlled trial (RCT) complemented by qualitative research on innovative group-based intervention for people with Multiple Sclerosis (MS) performed in the primary health care and organized in collaboration with the services provided by a hospital's outpatient clinic. The RCT will be conducted by Nordland Hospital Trust, Bodø (NLSH), in collaboration with UiT The Arctic University of Norway (UiT) and the Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway (NST). The overall purpose of the RCT is to demonstrate whether high-intensity individualised group-based core stability training (GroupCoreSIT) performed by physiotherapists (PTs) in the primary health care has effect on balance, walking and activities of daily living (ADL) in people with MS compared to standard care. Changes in quality of life and costs will also be studied to conclude whether the intervention is cost-effective. The qualitative study contains three parts. The first part aims to investigate users' experiences from participating in the new group intervention and in standard care. The researchers will particularly focus on reflections regarding content, feasibility, potential changes in ADL, self-management, and continuity of care. The second part will investigate how the PTs act and interact with the group while conducting the intervention, particularly how individualization is carried out, and the PTs' reflections from participating in the education and performance of the intervention. The third part explores health professionals' reflections regarding coordination of care in people with MS.

Read the detailed description

This research project first aims to compare the effects of high-intensity individualized group-based core stability training (GroupCoreSIT) for people with MS with standard care in the primary health care focusing on balance, walking, ADL, quality of life and cost-effectiveness. Secondly, the project aims to investigate patients' experiences from participating in the intervention and in standard care, particularly addressing reflections regarding content, relevance and feasibility, changes in ADL, continuity of care, self-management. The third aim is to investigate how the PTs act and interact with the group while conducting the intervention, particularly how individualization is carried out, and the PTs' reflections from participating in the education and performance of the intervention. Finally, changes in patients' pathways and coordination represent another main objective of this project.

The RCT: hypothesis, study outcomes and measures:

High-intensity individualised group-based core stability training performed at the municipal PTs' facilities, complemented by home exercises, will improve balance, walking, ADL, quality of life and cost-effectiveness. This is reflected in the primary and secondary outcomes.

RCT will be conducted in collaboration with the outpatient clinic for people with MS at the Nordland Hospital Trust, Bodø, together with six municipalities in Nordland County. The municipalities are included: Bodø, Rana, Meløy, Rødøy, Vågan and Fauske. The out-patient clinic agreed to recruit the participants by sending a written invitation to people with MS in the selected municipalities, fulfilling the inclusion criteria. Six PTs with expertise in neurological physiotherapy agreed to conduct the intervention. These PTs will attend a four days practical and theoretical training on the intervention, with 1-2 follow up videoconferences during the study.

A prospective RCT will be conducted, in which 72 persons with MS will participate, undergo a 6-week intervention, and be followed up for 6 months. Participants will be randomly assigned to two arms in a 1:1 ratio. Participants in the intervention arm A will be offered individualised group-based core stability training termed GroupCoreSIT at the PTs facilities, complemented with home exercises. Participants in the control arm B will be offered standard care. Significant improvements in outcomes are expected for the intervention arm compared to standard care. Randomisation will be stratified by European Disability Score Scale (EDSS) to minimize selection bias and preserve homogeneity between arms. Randomisation and data collation will be performed using Remote Data Entry (WebCRF), an Internet-based solution developed by the Norwegian University of Science and Technology (NTNU). The researchers aim to recruit all subjects within 5 months.

After enrolment, the PTs responsible for performing the intervention, will conduct an individual assessment of the participants in arm A as a basis for individualisation in the group based intervention.

Each training group will consist of three participants. The training sessions will last for 60 minutes, performed three days per week, for six weeks, between 10 am and 5 pm. A total of 32 exercises with up to 5 levels of difficulty are described and illustrated by photos, will be available in an "exercise bank". 10-12 repetitions for each exercise with good quality of movement will be performed. Every session will end with active stretching/active relaxation and instructions for home exercises. The participants will perform 30-minute of exercises, optional to divide into smaller intervals, at home two days per week when there are no organized group training.

Intervention arm A: the participants will perform the training program: GroupCoreSIT in the facilities of the municipal physiotherapist.

Control arm B: the participants in the control group will receive standard care, i.e. following their ordinary physiotherapy services and/or routines/activities.

Procedures and tests The trial will be restricted to patients who have volunteered and provided written informed consent in accordance with the Declaration of Helsinki and the Ethics Committee procedures.

At enrolment, a neurologist will do the EDSS screening, medical history, type of MS and medications. An appropriately trained PT, also blinded to the arm membership, will perform a standardized assessment for all the participants using relevant tests and provide the activity monitor. The following baseline information will be collected and then inserted electronically in the WebCRF system used also to randomize the patients:

  1. Medical history, type of MS, EDSS, age, gender, weight, height, medications, physiotherapy during the previous 6 months.
  2. Two primary outcomes measuring balance in sitting, standing and walking.
  3. Nine secondary outcomes measuring balance, waling, activities of daily living (ADL), quality of life and physical activity At 1 week, 3 months and 6 months post intervention all the participants will undergo the same standardized assessment performed at baseline.

Exercise, activity and disease monitoring On a weekly basis all the participants will record: changes in medication, general wellbeing (qualitative self-score), exacerbations, and physical activities using a diary. The ActiGraph monitor will be used 1 week prior to intervention, 1 week post intervention and following the 3 and 6 months testing, demonstrated and delivered to the subjects by the test PT. In addition, participants in arm A will record: degree of exhaustion following group sessions (Borg scale) and home exercise completion (in the training diary).

An intention-to-treat analysis will be performed on all randomised subjects and will serve as the primary analysis for all outcomes in this study. The data analysis will be carried out using SPSS. Possible differences between the groups at baseline will be calculated by using independent sample t-test for continuous variables and chi-square for categorical variables. Primary outcomes, changes in balance and walking between the groups will be calculated by using independent sample t-test.

A cost-utility analysis will be conducted using healthcare system costs and quality adjusted life years (QALYs). QALYs will be calculated based on the answers of the Health Questionnaire (EQ-5D-3L) used to measure changes in patients' quality of life. The incremental cost-effectiveness ratio (ICER) will be computed as differential costs between intervention arm and standard arm over the study period, and differential QALYs. Healthcare utilisation (including hospitalisations, emergency department admissions, outpatients visits, examinations, primary care visits, rehabilitation) and related costs will be collected through the hospitals' electronic patient journal (DIPS), from the Norwegian Patient Registry and The Norwegian Health Economics Administration's (HELFO) system. This secondary outcome will provide relevant knowledge regarding new effective method in organising healthcare services. This can be used as a basis for decision making regarding large-scale implementation of rehabilitation.

Patients' experiences:

The patients' experiences with the intervention will be examined through qualitative research interviews. The interviews will be conducted on a sample of 8-10 participants from the intervention and the control arm twice; at the end of intervention and 6 months post intervention. In accordance with qualitative methods, the researchers will select the sample strategically to promote breadth and variety of data production. Variation in training groups, EDSS, age, gender and time since diagnosis are considered to be important. The interviews will take place in participants' homes or another convenient place in their municipality. The interview topics include: the first assessment/consultation, the group situation, content of training, intensity/quantity, pros and cons, home-exercises and ADL. The same number of subjects from the control group will be interviewed regarding their experiences with standard care, investigating the same topics. In order to provide insight into the users' experiences beyond the intervention period the scope for the second interviews is: retrospective reflections regarding wellbeing and coping with ADL in the period before, during and after the intervention, self-management, and continuity of care, pros and cons regarding the intervention and standard care. A theme-based interview guide will be used as well as audio recordings of the interviews. The material will be transcribed and analyzed using Systematic Text Condensation applying phenomenology of the body, enactive theory complemented by neurosciences as a theoretical framework.

Physiotherapists' performance of intervention and experiences:

What the PTs emphasize in their individual assessment prior to the first group session will be investigated through observation and videotaping of the assessment of one patient in each training group (12 observations). These observations will be complemented by qualitative research interview with the actual PT (12 interviews) to illuminate the PTs' reflections regarding the assessment, planning of the group sessions, choices of exercises and goals for the individual. To investigate how the PTs' tailor the intervention in situ, how they act and interact with the participants, one session in each group will be observed and videotaped (12 observations). To illuminate the PTs' reflections regarding education in the intervention, experiences from conducting it, particularly focusing on considerations regarding goal attainment, individualization in a group setting and home exercises, the PTs will be interviewed at the end of each training group period (12 interviews). An observation guide, a hand held video-camera and a theme-based interview guide will be used as well as audio recordings of the interviews. The material will be transcribed and analysed using Systematic Text Condensation applying phenomenology of the body, enactive theory complemented by neurosciences and practice knowledge as a theoretical framework.

Changes in patient's pathway and coordination of care:

In 2007 The Northern Norway Regional Health Authority (Helse Nord RHF) reported 650 persons with MS, the selected outpatient clinic has 300 persons enrolled, and prevalence and incidence in Nordland County have recently increased to a high risk area for MS. Courses for newly diagnosed persons have priority in the specialist care and current offer of complex rehabilitation, included high intensity physiotherapy is provided by the rehabilitation unit at UNN, The Rehabilitation Centre, the Kurbad of North Norway, Valnesfjord Rehabilitation Centre, supplemented by The National Hakadal MS centre. These institutions are currently characterised by long waiting lists. A system for early admission to neurological physiotherapy, and particularly to high intensity programs in the primary health care, is not established within the coordination of care for people with MS. Referral to municipality physiotherapy is not systematic, waiting lists in the primary health care are long, and services are often general and not specifically addressing the needs for people with MS.

To explore coordination of care between the outpatient clinics for people with MS and the municipalities regarding high intensity physiotherapy, qualitative interviews will be conducted with selected health personnel (MS-nurses, neurologists, PTs, a total of 8-10 subjects) at the hospitals' outpatient clinics and in municipalities (general practitioners, PTs, a total of 8-10 subjects), before the intervention (for the standard care) and after the RCT (for the new organizational model). The interviews will focus on structures for collaboration and content of service.

Being tested
GroupCoreSIT, Standard care
Keywords
physical therapy, group-based, core stability, balance, movement quality, somatosensory stimulation, coordination
Medical subject headings
Multiple Sclerosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GroupCoreSITBehavioural

    Also called Group based individualised stability training, Group based individualised balance training

    Each group session lasts for 60 minutes. The physiotherapist will chose from an "exercises bank" of 32 exercises, each having up 5 levels of difficulty that are described and illustrated by photos. All exercises demand core activation, emphasise normal movement and emphasise somatosensory integration, feed forward and feed back strategies essential for balance.10-12 repetitions for each exercise with good quality of movement will be performed. Every session will start with exploring standing balance and end with active stretching/active relaxation, re-exploring balance and instructions for home exercises. The participants will perform 30-minute of exercises, optional to divide into smaller intervals, at home two days per week when there are no organized group training.

  • Standard careBehavioural

    The control group receive standard care, which means to follow their ordinary physiotherapy services and/or routines/activities. The content of standard care may vary, and will be recorded for all the participants.

Study groups in NCT02522962
Study groupRoleWhat they receive
GroupCoreSITExperimentalBefore the group training starts, the physiotherapist in charge of the group does a clinical assessment of each participant in order to individualise the training. Each training group will consist of three participants. The training sessions will last for 60 minutes, performed three days per week, for six weeks, between 10 am and 5 pm.
Receives: Behavioral: GroupCoreSIT
Standard careActive comparatorThe control group receive standard care, which means to follow their ordinary physiotherapy services and/or routines/activities. The content of standard care may vary, and will be recorded for all the participants.
Receives: Behavioral: Standard care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Trunk Impairment Scale modified Norwegian Version

    The outcome measures sitting balance

    Measured: Baseline

  2. Measure change in the outcome: Trunk Impairment Scale modified Norwegian Version

    The outcome measures sitting balance

    Measured: 1 week post intervention

  3. Measure change in the outcome: Trunk Impairment Scale modified Norwegian Version

    The outcome measures sitting balance

    Measured: 3 months post intervention

  4. Measure a change in the outcome: Trunk Impairment Scale modified Norwegian Version

    The outcome measures sitting balance

    Measured: 6 months post intervention

  5. Mini-Balance Evaluation Systems Test

    The outcome measures standing and walking balance

    Measured: baseline

  6. Measure a change in the outcome: Mini-Balance Evaluation Systems Test

    The outcome measures standing and walking balance

    Measured: 1 week post intervention

  7. Measure a change in the outcome:Mini-Balance Evaluation Systems Test

    The outcome measures standing and walking balance

    Measured: 3 months post intervention

  8. Measure a change in the outcome: Mini-Balance Evaluation Systems Test

    The outcome measures standing and walking balance

    Measured: 6 months post intervention

Secondary outcomes (35)
  1. 10-Meter Walk Test

    The outcome measures the speed of 10 meter walking

    Measured: Baseline

  2. Measure a change in the outcome: 10 Meter Walk Test

    The outcome measures the speed of 10 meter walking

    Measured: 1 week post intervention

  3. Measure a change in the outcome:10 Meter Walk Test

    The outcome measures the speed of 10 meter walking

    Measured: 3 months post intervention

  4. Measure a change in the outcome: 10 Meter Walk Test

    The outcome measures the speed of 10 meter walking

    Measured: 6 months post intervention

  5. 2-Minutes Walk Test

    The outcome measures the distance walked in 2 minutes

    Measured: Baseline

  6. Measure a change in the outcome: 2-Minutes Walk Test

    The outcome measures the distance walked in 2 minutes

    Measured: 1 week post intervention

  7. Measure a change in the outcome:2-MinutesWalk Test

    The outcome measures the distance walked in 2 minutes

    Measured: 3 months post intervention

  8. Measure a change in the outcome:2-Minutes Walk Test

    The outcome measures the distance walked in 2 minutes

    Measured: 6 months post intervention

  9. Rivermead Visual Gait Assessment

    The outcome measures quality of movement in walking

    Measured: Baseline

  10. Measure a change in the outcome:Rivermead Visual Gait Assessment

    The outcome measures quality of movement in walking

    Measured: 1 week post intervention

  11. Measure a change in the outcome:Rivermead Visual Gait Assessment

    The outcome measures quality of movement in walking

    Measured: 3 months post intervention

  12. Measure a change in the outcome:Rivermead Visual Gait Assessment

    The outcome measures quality of movement in walking

    Measured: 6 months post intervention

  13. MS Walking Scale-12

    a self-report form with 12 questions where limitations in various aspects of walking in the past two weeks are detected.

    Measured: Baseline

  14. Measure a change in the outcome:MS Walking Scale-12

    a self-report form with 12 questions where limitations in various aspects of walking in the past two weeks are detected.

    Measured: 1 week post intervention

  15. Measure a change in the outcome:MS Walking Scale-12

    a self-report form with 12 questions where limitations in various aspects of walking in the past two weeks are detected.

    Measured: 3 months post intervention

  16. Measure a change in the outcome: MS Walking Scale-12

    a self-report form with 12 questions where limitations in various aspects of walking in the past two weeks are detected.

    Measured: 6 months post intervention

  17. Multiple Sclerosis Impact Scale-29

    A self-report form with 29 items which records limitations in various aspects of ADL

    Measured: Baseline

  18. Measure a change in the outcome:Multiple Sclerosis Impact Scale-29

    A self-report form with 29 items which records limitations in various aspects of ADL

    Measured: 1 week post intervention

  19. Measure a change in the outcome:Multiple Sclerosis Impact Scale-29

    A self-report form with 29 items which records limitations in various aspects of ADL

    Measured: 3 months post intervention

  20. Measure a change in the outcome:Multiple Sclerosis Impact Scale-29

    A self-report form with 29 items which records limitations in various aspects of ADL

    Measured: 6 months post intervention

  21. The Patient Global Impression of Change

    a self-report form that measures the subject's perceptions of change

    Measured: 1 week post intervention

  22. Measure a change in the outcome: Patient Global Impression of Change

    a self-report form that measures the subject's perceptions of change

    Measured: 3 months post intervention

  23. Measure a change in the outcome: Patient Global Impression of Change

    a self-report form that measures the subject's perceptions of change

    Measured: 6 months post intervention

  24. ActiGraph activity monitor.

    The outcome measures physical activity

    Measured: baseline

  25. Measure a change in the outcome:ActiGraph activity monitor.

    The outcome measures physical activity

    Measured: 1 week post intervention

  26. Measure a change in the outcome:ActiGraph activity monitor

    The outcome measures physical activity

    Measured: 3 months post intervention

  27. Measure a change in the outcome:ActiGraph activity monitor

    The outcome measures physical activity

    Measured: 6 months post intervention

  28. Multiple Sclerosis Quality of Life-54 (MSQOL-54)

    The outcome measures the participants' health related quality of life.

    Measured: Baseline

  29. Measure a change in the outcome:Multiple Sclerosis Quality of Life-54 (MSQOL-54)

    The outcome measures the participants' health related quality of life.

    Measured: 1 week post intervention

  30. Measure a change in the outcome:Multiple Sclerosis Quality of Life-54 (MSQOL-54)

    The outcome measures the participants' health related quality of life.

    Measured: 3 months post intervention

  31. Measure a change in the outcome:Multiple Sclerosis Quality of Life-54 (MSQOL-54)

    The outcome measures the participants' health related quality of life.

    Measured: 6 months post intervention

  32. Health Questionnaire (EQ-5D-3L)

    The outcome measures the participants' health quality of life.

    Measured: Baseline

  33. Measure a change in the outcome:Health Questionnaire (EQ-5D-3L)

    The outcome measures the participants' quality of life.

    Measured: 1 week post intervention

  34. Measure a change in the outcome:Health Questionnaire (EQ-5D-3L)

    The outcome measures the participants' quality of life.

    Measured: 3 months post intervention

  35. Measure a change in the outcome:Health Questionnaire (EQ-5D-3L)

    The outcome measures the participants' quality of life.

    Measured: 6 months post intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2015 (estimated)
  2. Study startSep 2015
  3. Primary completionSep 2016
  4. Study completionDec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02522962
Sponsor's protocol ID
2015/1715 REK
Acronym
GroupCoreSIT
Status last verified
Feb 2019
First submitted
10 Aug 2015
Last updated
13 May 2019
Results posted
No
Data monitoring committee
No

Publications

  • Arntzen EC, Straume BK, Odeh F, Feys P, Zanaboni P, Normann B. Group-Based Individualized Comprehensive Core Stability Intervention Improves Balance in Persons With Multiple Sclerosis: A Randomized Controlled Trial. Phys Ther. 2019 Aug 1;99(8):1027-1038. doi: 10.1093/ptj/pzz017.

    PubMed 30722036

Questions about this trial

What is this clinical trial studying?

A study testing GroupCoreSIT in people with Multiple Sclerosis, run by Nordlandssykehuset HF at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Trunk Impairment Scale modified Norwegian Version (time frame: Baseline). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02522962, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2019; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in